Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5647313 | The Journal of Allergy and Clinical Immunology: In Practice | 2016 | 11 Pages |
Abstract
The new ESID definition for CVID still fails to exclude a large number of patients with severe T-cell defect. We propose a new definition (DEFI 2015) that excluded more patients with a T-cell defect and consider these patients as LOCID. This population has a poor outcome and should be considered as a distinct group requiring specific care.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Rémi MD, Laurence MD, David MD, Marion MD, Claire MD, PhD, Eric MD,